News - Page 20 of 39 - TIAP
MI’s Fanny Sie to speak about 3D printing trends at two Toronto events
Fanny Sie, MaRS Innovation's head of imaging technologies and a manager in the Technology & Venture Development group, is speaking about bioprinting trends at two Toronto conferences this weekend.
Sie is MI's commercialization lead on the Bioprinter, a licensenable technology from the University of Toronto and Sunnybrook Health Sciences Centre.
Watch her interview on bioprinting with TVO's The Agenda, which aired in June 2013.
First up is Digifest, an international festival celebrating digital creativity, which runs from May 8 to 10 at the Corus ...
Read more
MaRS Innovation Statement on 2014 Ontario Budget
TORONTO, ON (May 2, 2014) – MaRS Innovation congratulates the government's deepened commitment to support the life sciences through research and innovation funding. In particular, the new $30 million Life Sciences Seed Venture Capital Fund will create a partnership between the Province of Ontario, the private sector and hospital foundations to finance Ontario-based life sciences companies.
“As co-designers of this venture capital fund and one of its many champions, MaRS Innovation welcomes this news,” says Dr. Raphael (Rafi) Hofstein, president and CEO. ...
Read more
UTEST co-founder Lyssa Neel on start-up success
The University of Toronto Early-Stage Technology (UTEST) program's second cohort is coming to a close, with applications for a third cohort open until April 17.
The incubator program, a University of Toronto and MaRS Innovation joint partnership, helps affiliates of the university develop and commercialize their ideas. Successful applicants receive twelve months of mentoring to incubate their technology into a product, with access to immediate follow-on investment of up to $500,000 through MaRS Innovation. Access to provincial and federal funding resources is also available, ...
Read more
Portfolio snapshot: UTEST in the Wall Street Journal, OtoSim & Sylleta win pitch competitions
Here's a snapshot of some recent portfolio activity:
UTEST, the early-stage technology accelerator MI runs in partnership with the University of Toronto, was cited in the Wall Street Journal as part of what makes Toronto the best place to build a start-up in Canada and the eighth-best place in the world. Applications for UTEST's the third cohort are open until Thursday, April 17, 2014.
OtoSim Inc. placed first out of 20 companies in the Venture Pitch competition at the Fundica Funding Roadshow for ...
Read more
WaveCheck breast cancer technology receives $100,000
OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May
TORONTO, April 8, 2014 -- People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR).
The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over $50,000 from over 500 supporters worldwide in two months last ...
Read more
MaRS Innovation Industry Access Program (MI-IAP) accepting applications until April 10
Researchers working in orphan indications, drug delivery devices, big data and other key areas invited to submit a brief Statement of Interest
The MaRS Innovation Industry Access Program (MI-IAP) is a simple, formalized process for marketing early-stage technologies to MI's industry partners: Baxter, LifeLabs (formerly CML Healthcare), GSK, Johnson & Johnson, Pfizer and Merck.
The program's goal is to secure funding for researchers within MI's membership through these collaborative, strategic R&D partnership programs.
First run in November 2013, the MI-IAP allows researchers to easily ...
Read more
MI’s Joel Liederman opens medical device panel at BioTransfer 2014
Joel Liederman, MaRS Innovation's vice-president of Business Development and Commercialization for physical sciences, is attending BioTransfer 2014 on March 18 to chair the Medical Devices Committee.
This is the first year that Toronto is hosting the BioTransfer conference. Presenters at the one-day event will discuss biotherapeutics, diagnosis and medical technology. The conference's goal is to share knowledge on current trends in the industry and to stimulate collaboration with private sector companies.
As chair, Liederman will open the medical devices committee panel discussion on Tuesday afternoon ...
Read more
UTEST’s co-directors share what makes for a great start-up application
The University of Toronto Early-Stage Technology (UTEST) program helps U of T students, recent grads or professors to take their ideas to market.
Successful applicants get mentoring, funding and work space over a 12-month period as they advance their ideas. The program is co-managed by MaRS Innovation and the University of Toronto.
In a U of T "Spotlight on Startups" news article, Brianna Goldberg spoke with Mike Betts and Kurtis Scissons, UTEST co-directors, on what makes for a great applicant.
Here's an excerpt:
What are ...
Read more
Whirlscape exits beta, launches version 2.0 of the Minuum keyboard
Whirlscape Inc., a graduate of the University of Toronto Early-Stage Technology (UTEST) program's cohort graduate, exits beta with the version 2.0 release of Minuum, their hit "small keyboard for big fingers."
Whirlscape Inc. graduated from the University of Toronto Early-Stage Technology (UTEST) program's first cohort. UTEST is accepting applications for its third cohort until April 17. Click here to apply.
Version 2.0's release is already a popular download for Android Apps in the Google Play store. Users can get a 30-day free trial of Minuum and ...
Read more
Techvibes highlights UTEST’s third cohort
Techvibes, a publication dedicated to covering latest trends in start-up culture and social and mobile news, covered the University of Toronto Early-Stage Technology (UTEST) program's call for applications in an online article on March 1, 2014.
Applications for UTEST's third cohort are open until April 17, 2014. Co-directors Kurtis Scissons and Mike Betts will work with selected applicants for a period of twelve months to guide their idea to market. Successful applicants receive work space for a year, mentorship, $30,000 in funding ...
Read more